183C91
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
AbstractBackground and objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and…
The objective of this study was to investigate the pharmacokinetics, dose proportionality, and tolerability of a range of single…
Zolmitriptan is a serotonin 5-HT1B/1D receptor agonist that is highly effective for the acute treatment ofmigraine.[1] Following…
HeadingAbstract
Background. Zolmitriptan is a 5HT1B/1D receptor agonist effective in the acute treatment of migraine. Clinical…
Two preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray were conducted, each involving 12…
SummaryAbstractZolmitriptan is a selective serotonin 5-HT1b/id receptor agonist (‘triptan’). Its efficacy and tolerability have…
AIMS
Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT1B/1D receptor agonist developed for the acute oral treatment of…
SummaryTwo studies were conducted in healthy volunteers to evaluate the effects of rifampicin and cimetidine on the…
AbstractObjective: This study investigated potential pharmacokinetic or pharmacodynamic interactions between the novel anti…